SOURCE: Empire Genomics

April 24, 2008 11:07 ET

Empire Genomics' Founder Receives Prestigious Award at American Association for Cancer Research Meeting for Development of aCGH Technology

BUFFALO, NY--(Marketwire - April 24, 2008) - Norma J. Nowak, PhD, a internationally recognized leader in the fields of genetics and genomics and Founder of Empire Genomics was awarded the Team Science Award from the American Association for Cancer Research (AACR) for her work in the development of CGH (Comparative Genomic Hybridization) and array CGH technologies. Dr. Nowak and colleagues from the University of California, San Francisco and Lawrence Berkeley National Laboratory received the award at the 2008 AACR meeting in San Diego.

The AACR Team Science Award recognizes an outstanding interdisciplinary research team for its innovative and meritorious science that has advanced or likely will advance our fundamental knowledge of cancer or a team that has applied existing knowledge to advance the detection, diagnosis, prevention or treatment of cancer.

Array CGH is a rapidly growing technology applied in basic and clinical research studies aimed at understanding the molecular genetic mechanisms of diseases. Dr. Nowak is utilizing this novel technology at Empire Genomics.

"Not only is it gratifying to win this award with my colleagues, but having lost my husband to cancer it is very exciting to work with clinicians who are actively looking to work with Empire to develop better diagnostics and therapeutics for leukemia, lymphoma, and other forms of cancer through the application of aCGH technology," says Dr. Nowak.

"This award is further support for the level of expertise and experience that guides everything that we do at Empire Genomics. We truly are working with pioneers in Dr. Nowak and her lab," said Anthony Johnson, President and CEO of Empire Genomics.

About Empire Genomics:

Empire Genomics, based in Buffalo, New York, utilizes proprietary techniques to identify and quantify chromosomal abnormalities. Specifically the company has evolved array-based Comparative Genomic Hybridization (aCGH) by developing microarrays that utilize discrete segments of DNA generated from the RPCI BAC clones. These are of considerable value as they served as the foundation for the human genome sequence, and have vast potential towards the development of diagnostic tests and therapies. The company was founded on the research expertise of Dr. Norma Nowak reflected by her more than 100 peer reviewed research publications. More information on Empire Genomics is available at www.empiregenomics.com.

Contact Information